Literature DB >> 32966713

Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.

Otto O Yang1, F Javier Ibarrondo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32966713     DOI： 10.1056/NEJMc2027051

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.

Authors:  Maria Tsilika; Esther Taks; Konstantinos Dolianitis; Antigone Kotsaki; Konstantinos Leventogiannis; Christina Damoulari; Maria Kostoula; Maria Paneta; Georgios Adamis; Ilias Papanikolaou; Kimon Stamatelopoulos; Amalia Bolanou; Konstantinos Katsaros; Christina Delavinia; Ioannis Perdios; Aggeliki Pandi; Konstantinos Tsiakos; Nektarios Proios; Emmanouela Kalogianni; Ioannis Delis; Efstathios Skliros; Karolina Akinosoglou; Aggeliki Perdikouli; Garyfallia Poulakou; Haralampos Milionis; Eva Athanassopoulou; Eleftheria Kalpaki; Leda Efstratiou; Varvara Perraki; Antonios Papadopoulos; Mihai G Netea; Evangelos J Giamarellos-Bourboulis
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

2.  SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.

Authors:  Evangelos Terpos; Dimitris Stellas; Margherita Rosati; Theodoros N Sergentanis; Xintao Hu; Marianna Politou; Vassiliki Pappa; Ioannis Ntanasis-Stathopoulos; Sevasti Karaliota; Jenifer Bear; Duncan Donohue; Maria Pagoni; Elisavet Grouzi; Eleni Korompoki; George N Pavlakis; Barbara K Felber; Meletios A Dimopoulos
Journal:  Eur J Intern Med       Date:  2021-05-18       Impact factor: 7.749

3.  Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.

Authors:  Natalia Sherina; Antonio Piralla; Likun Du; Hui Wan; Makiko Kumagai-Braesch; Juni Andréll; Sten Braesch-Andersen; Irene Cassaniti; Elena Percivalle; Antonella Sarasini; Federica Bergami; Raffaella Di Martino; Marta Colaneri; Marco Vecchia; Margherita Sambo; Valentina Zuccaro; Raffaele Bruno; Michele Sachs; Tiberio Oggionni; Federica Meloni; Hassan Abolhassani; Federico Bertoglio; Maren Schubert; Miranda Byrne-Steele; Jian Han; Michael Hust; Yintong Xue; Lennart Hammarström; Fausto Baldanti; Harold Marcotte; Qiang Pan-Hammarström
Journal:  Med (N Y)       Date:  2021-02-10

Review 4.  Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.

Authors:  Jorge Pérez-Galarza; César Prócel; Cristina Cañadas; Diana Aguirre; Ronny Pibaque; Ricardo Bedón; Fernando Sempértegui; Hemmo Drexhage; Lucy Baldeón
Journal:  Vaccines (Basel)       Date:  2021-01-29

5.  Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.

Authors:  Lucas Ferrante; Luiz Henrique Duczmal; Eduardo Capanema; Wilhelm Alexander Cardoso Steinmetz; Alexandre Celestino Leite Almeida; Jeremias Leão; Ruth Camargo Vassão; Philip Martin Fearnside; Unaí Tupinambás
Journal:  Prev Med Rep       Date:  2022-02-28

Review 6.  Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice.

Authors:  Abdulla A Damluji; Robert H Christenson; Christopher deFilippi
Journal:  J Am Heart Assoc       Date:  2021-02-23       Impact factor: 5.501

7.  A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays.

Authors:  Brad Poore; Robert D Nerenz; Dina Brodis; Charles I Brown; Mark A Cervinski; Jacqueline A Hubbard
Journal:  Clin Biochem       Date:  2021-06-09       Impact factor: 3.281

8.  The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia.

Authors:  Lucas Ferrante; Sophia Livas; Wilhelm Alexander Steinmetz; Alexandre Celestino Leite Almeida; Jeremias Leão; Ruth Camargo Vassão; Unaí Tupinambás; Philip Martin Fearnside; Luiz Henrique Duczmal
Journal:  J Racial Ethn Health Disparities       Date:  2021-06-21

9.  Not just antibodies: B cells and T cells mediate immunity to COVID-19.

Authors:  Rebecca J Cox; Karl A Brokstad
Journal:  Nat Rev Immunol       Date:  2020-10       Impact factor: 53.106

10.  Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.

Authors:  F Javier Ibarrondo; Christian Hofmann; Ayub Ali; Paul Ayoub; Donald B Kohn; Otto O Yang
Journal:  mBio       Date:  2021-12-07       Impact factor: 7.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.